From: One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
MF-DPI 800 μg QD PM (n = 282) | MF-DPI 400 μg BID (n = 283) | Placebo (n = 263) | |
---|---|---|---|
Total COPD symptom scores (daytime) | |||
Baseline | 2.66 | 2.78 | 2.64 |
Longitudinal average | -0.36 | -0.57† | -0.11 |
Total COPD symptom scores (nighttime) | |||
Baseline | 2.54 | 2.73 | 2.65 |
Longitudinal average | -0.30 | -0.50† | -0.12 |
Daytime symptom scores | |||
Difficulty Breathing | |||
Baseline | 1.06 | 1.14 | 0.99 |
Longitudinal average | -0.11‡ | -0.23† | 0.02 |
Coughing | |||
Baseline | 0.92 | 0.91 | 0.97 |
Longitudinal average | -0.14 | -0.16 | -0.10 |
Wheezing | |||
Baseline | 0.70 | 0.74 | 0.68 |
Longitudinal average | -0.12 | -0.18† | -0.04 |
Nighttime Symptom Scores | |||
Difficulty breathing | |||
Baseline | 1.00 | 1.10 | 1.01 |
Longitudinal average | -0.10 | -0.18† | 0.01 |
Coughing | |||
Baseline | 0.90 | 0.91 | 0.96 |
Longitudinal average | -0.12 | -0.16 | -0.08 |
Wheezing | |||
Baseline | 0.66 | 0.73 | 0.69 |
Longitudinal average | -0.08 | -0.17† | -0.05 |